LVS$52.81+1.7%Cap: $35.0BP/E: 19.552w: [=====|-----](Apr 26)
Las Vegas Sands operates Marina Bay Sands in Singapore (the only competitor is Genting's Resorts World Sentosa) and 74.8% of Sands China in Macao. Coming into Q1 2026 the dominant bear thesis was simple: "Singapore's $806M Q4 EBITDA is luck — the 4.54% rolling chip win rate ran 50bps above theoretical, mean-reversion is coming." The 10-Q filed April 24 tested that thesis. It failed — but for a reason the market hasn't yet absorbed.
What the filing says
Marina Bay Sands rolling chip volume surged to $17,965M in Q1 2026, up 123.8% YoY from $8,028M. The win rate normalized to 3.56%, essentially at the revised 3.6% theoretical (smart-table data). Translation: luck normalized; earnings grew anyway. MBS Q1 EBITDA: $788M, margin 53.0%. Casino revenue +31.4%.
Macao posted aggregate margin 30.2% (low end of management's "low 30s" guide), recovering from Q4's 28.9% miss. Sands China captured 25.7% market share, the highest in two-plus years, with VIP rolling share up roughly 250bps to ≈24%. Driver: the Londoner Grand premium conversion completed April 2025, with Londoner rolling chip volume +173.5% YoY (vs. sector VIP baccarat GGR +35.4% per DICJ). Sands gained share while cutting reinvestment to 21-22% of mass revenue — the cleanest signal that the moat is product, not promotional bribery.
Capital return in Q1 alone: $746M buybacks + $202M dividend = $948M. Annualizes to ≈$3.8B against a ≈$35B market cap, an 11% yield. The AAEC litigation — a 14-year-old $11.95B claim — was dismissed with final judgment for LVS on March 4, 2026.
What the market thinks
LVS trades at $52.81. The stock fell -8.4% the week of the print despite a clean beat (EPS $0.91 vs $0.76, fourth straight beat). Sell-side stayed bullish post-print: Macquarie $70, Stifel $74, Mizuho $67, Barclays $65. Mean target $69.51. Forward P/E 14.4. Options: max pain $55 (above current), IV Rank 46, P/C OI 0.80. Working backward from current price with an 8% required return implies a 12-month EV around $57.
Our scenario-weighted EV: ≈$59.50 (35% bull $74 / 35% base $61 / 22% bear $44 / 8% tail $32). Edge ≈5% in price, ≈7% with dividend. Modest.
Why the gap exists
The mechanism is buried across two filings the same analyst rarely reads together. Genting Singapore is in the middle of its RWS 2.0 renovation: hotel inventory down 27% (1,200 rooms operational vs. 1,540 pre-renovation), 2025 net profit -32.6%, and "unavoidable disruptions" through 2027-2028. MBS opened Paiza Sky Palace Tower 2 VIP space in September 2025 — capacity met defection in a regulated two-property duopoly. Most LVS sell-side models do not carry the Genting reopen schedule.
A factor regression confirms it: 1-year β_FXI compressed from 0.33 (2-year) to 0.09. The China-consumer narrative anchoring 2024 sell-side models no longer fits the data. Idio share of variance: 84.6%. Post-print sellers were factor-driven, not thesis-driven.
Risks (ranked)
- Singapore VIP durability. The 10-Q does not explain why volume doubled. If Q2 prints below ≈$12B rolling chip volume, the share-grab thesis weakens. Q2 earnings July 22.
- Macao dividend tax extension. Requested January 19; "no assurance." All six concessionaires affected. If denied, structural rate increase across the sector.
- MBS Expansion timeline. $8B project, $2.8B spent. Company estimates June 2030 completion vs. July 2029 contractual deadline. Singapore government extension required.
- Parisian Macao. Q1 EBITDA -30.3% YoY on a 1.11% rolling chip win rate. Probably variance, but worth tracking.
- China consumer macro. Even with β_FXI compressed, a sharp deterioration would pressure all Asian gaming.
Catalysts
- May 5–7: WYNN and MGM Q1 earnings — Macao dividend tax disclosure status (cross-confirms LVS read).
- May 13–14: Genting Singapore Q1 — direct test of RWS competitive vacuum.
- Mid-May / mid-June: Macao DICJ monthly GGR — Sands China share trend.
- July 22: LVS Q2 — primary Singapore durability test.
- TBD 2026: Macao dividend tax extension decision.
What would change our mind
- Q2 MBS rolling chip volume below ≈$12B: pull-forward / one-time, share-grab less durable than supposed.
- Genting Q1 print stronger than expected: vacuum mechanism weaker; mean-reversion bear partially intact.
- Macao dividend tax denied: -3-5% to EPS across the sector.
- Sands China share giving back in DICJ April/May: Macao share gain not sticky.
- Insider activity context: a separate verification step rejected an early read of recent insider acquisitions as "$32M cash buying" — Form 4 codes show RSU grants (A), gifts to family trust (G), and a same-day option exercise + cashless cover (M+S). No Code-P open-market purchases. The structural case stands; the insider tailwind does not.
The opportunity is not enormous. It is real and time-bounded — the duopoly window closes when RWS 2.0 reopens, somewhere in 2027-2028. The base case sits at the current price; the bull case requires Q2 to confirm.
Evidence
| Evidence | Source | Credibility | LR |
|---|---|---|---|
| MBS Q1 2026 rolling chip volume $17,965M (+123.8% YoY); win rate normalized to 3.56% from 4.54%; revenue +31.4% | LVS 10-Q 2026-04-24, casino activity tables | 0.95 | 1.4 |
| MBS Q1 2026 EBITDA $788M, margin 53.0% — volume-driven, not luck-driven | LVS 10-Q 2026-04-24, segment data | 0.95 | 2.0 |
| Genting RWS hotel inventory -27% (1,200 vs 1,540 rooms); 2025 net profit -32.6%; "unavoidable disruptions" through 2027-2028 | Genting Singapore disclosures, IAG May 2025 | 0.9 | 2.5 |
| Macao industry VIP baccarat GGR Q1 2026 +35.4% YoY; total Macao GGR +14.3%; Sands China share 25.7% (highest 2y) | DICJ via MLCO 6-K Apr 24 2026; Macau Business / GGRAsia | 0.9 | 1.4 |
| Londoner Macao rolling chip volume +173.5% (≈5x sector); reinvestment cut to 21-22% of mass revenue | LVS 10-Q + DICJ cross-reference | 0.95 | 1.3 |
| Macao aggregate margin 30.2% (recovery from 28.9% Q4 miss, low end of "low 30s" guide); Parisian Macao EBITDA -30.3% on 1.11% rolling chip win rate | LVS 10-Q 2026-04-24, segment data | 0.95 | 1.3 |
| Q1 capital return $948M ($746M buybacks + $202M dividend); $817M remaining authorization | LVS 10-Q 2026-04-24 | 0.95 | 1.5 |
| AAEC v. VML $11.95B claim — final judgment for LVS, March 4, 2026 | LVS 10-Q 2026-04-24, litigation footnote | 0.95 | 1.4 |
| Macao dividend tax substitution agreement extension requested Jan 19, 2026; "no assurance such agreement will be granted" — sector-wide overhang affecting all 6 concessionaires | LVS 10-Q 2026-04-24, MLCO 6-K cross-reference | 0.95 | 0.85 |
| MBS Expansion $2.8B spent of $8B; company estimate June 2030 vs contractual deadline July 2029 | LVS 10-Q 2026-04-24, capital commitments footnote | 0.95 | 1.0 |
| Recent insider activity is RSU grants (Code A), gifts to Goldstein Trust (Code G), and same-day option exercise + cashless cover (Code M+S) — zero Code P open-market purchases | SEC Form 4 filings 2026-02-04, 2026-02-09, 2026-03-19 | 0.95 | 1.0 |
| LVS factor regression (1y, ending Apr 2026): 84.6% idio variance; β_SPY 0.51, β_XLY 0.35, β_FXI 0.09 (compressed from 0.33 in 2y window) | iev regress LVS, internal | 0.85 | 1.2 |
// comments (0)